Insider Transactions in Q4 2024 at Rhythm Pharmaceuticals, Inc. (RYTM)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 11
2024
|
Jennifer Chien EVP, Head of North America |
SELL
Open market or private sale
|
Direct |
66,861
-55.62%
|
$4,479,687
$67.15 P/Share
|
|
Nov 11
2024
|
Jennifer Chien EVP, Head of North America |
BUY
Exercise of conversion of derivative security
|
Direct |
60,981
+30.45%
|
$1,219,620
$20.58 P/Share
|
|
Nov 11
2024
|
Joseph Shulman Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
13,281
-79.75%
|
$876,546
$66.87 P/Share
|
|
Nov 11
2024
|
Joseph Shulman Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,281
+39.28%
|
$185,934
$14.09 P/Share
|
|
Nov 07
2024
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,688
-25.78%
|
$304,720
$65.0 P/Share
|
|
Nov 07
2024
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,688
+20.49%
|
$89,072
$19.02 P/Share
|
|
Nov 06
2024
|
Pamela J. Cramer Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct |
4,687
-25.77%
|
$281,220
$60.0 P/Share
|
|
Nov 06
2024
|
Pamela J. Cramer Chief Human Resources Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,687
+20.49%
|
$89,053
$19.02 P/Share
|